A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Hemodynamic Effects of Rolofylline Injectable Emulsion in the Treatment of Patients With Heart Failure

Trial Profile

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Hemodynamic Effects of Rolofylline Injectable Emulsion in the Treatment of Patients With Heart Failure

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2013

At a glance

  • Drugs Rolofylline (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 20 Apr 2012 Official title amended as reported by European Clinical Trials Database.
    • 17 Mar 2012 Additional locations (Czech Republic, Germany, Italy) added as reported by European Clinical Trials Database.
    • 17 Mar 2012 Planned number of patients changed from 16 to 66 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top